AAAAAA
Results:
1-9
|
Results: 9
Authors:
Lefrere, JJ
Lerable, J
Mariotti, M
Bogard, M
Thibault, V
Frangeul, L
Loiseau, P
Bouchardeau, F
Laperche, S
Pawlotsky, JM
Cantaloube, JF
Biagini, P
de Lamballerie, X
Izopet, J
Defer, C
Lepot, I
Poveda, JD
Dussaix, E
Gerolami, V
Halfon, P
Buffet-Janvresse, C
Ferec, C
Mercier, B
Marcellin, P
Martinot-Peignoux, M
Gassain, M
Merel, P
Lamoril, J
Coste, J
Roudet-Thoraval, F
Citation: Jj. Lefrere et al., Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay, J VIROL MET, 85(1-2), 2000, pp. 117-124
Authors:
Aubin, JT
Defer, C
Vidaud, M
Montreuil, MM
Flan, B
Citation: Jt. Aubin et al., Large-scale screening for human parvovirus B19 DNA by PCR: Application to the quality control of plasma for fractionation, VOX SANGUIN, 78(1), 2000, pp. 7-12
Authors:
Lemaire, JM
Courouce, AM
Defer, C
Bouchardeau, F
Coste, J
Agulles, O
Cantaloube, JF
Barlet, V
Barin, F
Citation: Jm. Lemaire et al., HCV RNA in blood donors with isolated reactivities by third-generation RIBA, TRANSFUSION, 40(7), 2000, pp. 867-870
Authors:
Martinot-Peignoux, M
Roudot-Thoraval, F
Mendel, I
Coste, J
Izopet, J
Duverlie, G
Payan, C
Pawlotsky, JM
Defer, C
Bogard, M
Gerolami, V
Halfon, P
Buisson, Y
Fouqueray, B
Loiseau, P
Lamoril, J
Lefrere, JJ
Marcellin, P
Citation: M. Martinot-peignoux et al., Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy, J VIRAL HEP, 6(6), 1999, pp. 435-443
Authors:
Saura, C
Courouce, AM
Pillonel, J
Costagliola, D
Flan, B
Defer, C
Coste, J
Rouzioux, C
Citation: C. Saura et al., Risk-benefit analysis of Nucleic Acid Testing: The French experience, BIOLOGICALS, 27(4), 1999, pp. 343-348
Authors:
Lefrere, JJ
Cantaloube, JF
Defer, C
Mercier, B
Loiseau, P
Vignon, D
Pawlotsky, JM
Biagini, P
Lerable, J
Rouger, P
Roudot-Thoraval, F
Ferec, C
Citation: Jj. Lefrere et al., Screening for HBV, HCV and HIV genomes in blood donations: shortcomings ofpooling revealed by a multicentre study simulating real-time testing, J VIROL MET, 80(1), 1999, pp. 33-44
Authors:
Mercier, B
Barclais, A
Botte, C
Cantalube, JF
Coste, J
Defer, C
Gautreau, C
Giannoli, C
Halfon, P
Lepot, I
Loiseau, P
Martial, J
Montcharmont, P
Merel, P
Ouzan, D
Ravera, N
Follana, J
Cesaire, R
Janot, C
Lemaire, JM
De Micco, P
Vezon, G
Ferec, C
Citation: B. Mercier et al., Prevalence of GBV C HGV RNA and GBV C HGV antibodies in French volunteer blood donors: Results of a collaborative study, VOX SANGUIN, 76(3), 1999, pp. 166-169
Authors:
LaPerche, S
Courouce, AM
Lemaire, JM
Coste, J
Defer, C
Cantaloube, JF
Citation: S. Laperche et al., GB virus type C hepatitis G virus infection in French blood donors with anti-NS5 isolated reactivities by recombinant immunoblot assay for hepatitis C virus, TRANSFUSION, 39(7), 1999, pp. 790-791
Authors:
Lunel, F
Poinsot, H
Bogard, M
Brechot, C
Defer, C
Duverlie, G
Fouqueray, B
Halfon, P
Lewine, P
Loiseau, P
Marcellin, P
Zarski, JP
Stuyver, L
Citation: F. Lunel et al., Prevalence and characteristics of genotype 2 subtypes in France, HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD, 1997, pp. 111-114
Risultati:
1-9
|